| pubmed-article:3225331 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3225331 | lifeskim:mentions | umls-concept:C0019623 | lld:lifeskim |
| pubmed-article:3225331 | lifeskim:mentions | umls-concept:C0795974 | lld:lifeskim |
| pubmed-article:3225331 | lifeskim:mentions | umls-concept:C1414235 | lld:lifeskim |
| pubmed-article:3225331 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:3225331 | pubmed:dateCreated | 1989-4-3 | lld:pubmed |
| pubmed-article:3225331 | pubmed:abstractText | A patient presented initially with a testicular mass, which on biopsy had morphological features consistent with malignant histiocytosis. The tumour cells labelled strongly with EBM/11, a murine monoclonal antibody with high specificity for cells of the human mononuclear phagocyte system. Subsequent clinical and laboratory studies confirmed the diagnosis. As poorly differentiated tumour cells reacted with EBM/11, this antibody may be useful in positively identifying malignant tumours with histiocytic differentiation from malignancies of other types where morphological detail alone is inconclusive in tumour classification. | lld:pubmed |
| pubmed-article:3225331 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3225331 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:3225331 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225331 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3225331 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:3225331 | pubmed:issn | 0021-9746 | lld:pubmed |
| pubmed-article:3225331 | pubmed:author | pubmed-author:McGeeJ OJO | lld:pubmed |
| pubmed-article:3225331 | pubmed:author | pubmed-author:GatterK CKC | lld:pubmed |
| pubmed-article:3225331 | pubmed:author | pubmed-author:KellyP MPM | lld:pubmed |
| pubmed-article:3225331 | pubmed:author | pubmed-author:McGovernMM | lld:pubmed |
| pubmed-article:3225331 | pubmed:author | pubmed-author:TheakerJ MJM | lld:pubmed |
| pubmed-article:3225331 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3225331 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:3225331 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3225331 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3225331 | pubmed:pagination | 1305-9 | lld:pubmed |
| pubmed-article:3225331 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:3225331 | pubmed:meshHeading | pubmed-meshheading:3225331-... | lld:pubmed |
| pubmed-article:3225331 | pubmed:meshHeading | pubmed-meshheading:3225331-... | lld:pubmed |
| pubmed-article:3225331 | pubmed:meshHeading | pubmed-meshheading:3225331-... | lld:pubmed |
| pubmed-article:3225331 | pubmed:meshHeading | pubmed-meshheading:3225331-... | lld:pubmed |
| pubmed-article:3225331 | pubmed:meshHeading | pubmed-meshheading:3225331-... | lld:pubmed |
| pubmed-article:3225331 | pubmed:meshHeading | pubmed-meshheading:3225331-... | lld:pubmed |
| pubmed-article:3225331 | pubmed:meshHeading | pubmed-meshheading:3225331-... | lld:pubmed |
| pubmed-article:3225331 | pubmed:meshHeading | pubmed-meshheading:3225331-... | lld:pubmed |
| pubmed-article:3225331 | pubmed:meshHeading | pubmed-meshheading:3225331-... | lld:pubmed |
| pubmed-article:3225331 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:3225331 | pubmed:articleTitle | EBM/11 reactivity in malignant histiocytosis. | lld:pubmed |
| pubmed-article:3225331 | pubmed:affiliation | University of Oxford, Nuffield Department of Pathology, John Radcliffe Hospital. | lld:pubmed |
| pubmed-article:3225331 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3225331 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3225331 | lld:pubmed |
